Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study

Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study

Advanced hepatocellular carcinoma (HCC) is an aggressive disease associated with poor prognosis. Tumor Treating Fields (TTFields) therapy is a non-invasive, loco-regional treatment approved for glioblastoma and malignant pleural mesothelioma. HCC preclinical and abdominal simulation data, together w...

Full description

Bibliographic Details
Main Authors: Eleni Gkika, Anca-Ligia Grosu, Teresa Macarulla Mercade, Antonio Cubillo Gracián, Thomas B. Brunner, Michael Schultheiß, Monika Pazgan-Simon, Thomas Seufferlein, Yann Touchefeu
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
hepatocellular carcinoma (HCC)
liver cancer
solid tumor
sorafenib
TTFields
Online Access:https://www.mdpi.com/2072-6694/14/6/1568

Internet

https://www.mdpi.com/2072-6694/14/6/1568

Similar Items